Madrigal Pharmaceuticals Inc.

AI Score

0

Unlock

324.32
17.24 (5.61%)
At close: Jan 22, 2025, 3:59 PM
324.71
0.12%
After-hours Jan 22, 2025, 05:10 PM EST

Madrigal Pharmaceuticals Statistics

Share Statistics

Madrigal Pharmaceuticals has 21.81M shares outstanding. The number of shares has increased by 9.61% in one year.

Shares Outstanding 21.81M
Shares Change (YoY) n/a
Shares Change (QoQ) 0.45%
Owned by Institutions (%) n/a
Shares Floating 18.39M
Failed to Deliver (FTD) Shares 2.21K
FTD / Avg. Volume 0.47%

Short Selling Information

The latest short interest is 4.73M, so 21.71% of the outstanding shares have been sold short.

Short Interest 4.73M
Short % of Shares Out 21.71%
Short % of Float 25.75%
Short Ratio (days to cover) 12.58

Valuation Ratios

The PE ratio is -11.57 and the forward PE ratio is -24.29.

PE Ratio -11.57
Forward PE -24.29
PS Ratio 0
Forward PS 6.9
PB Ratio 10.67
P/FCF Ratio -13.28
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Madrigal Pharmaceuticals Inc..

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.38, with a Debt / Equity ratio of 0.29.

Current Ratio 5.38
Quick Ratio 5.38
Debt / Equity 0.29
Total Debt / Capitalization 22.43
Cash Flow / Debt -2.77
Interest Coverage -29.93

Financial Efficiency

Return on equity (ROE) is -0.92% and return on capital (ROIC) is -72.82%.

Return on Equity (ROE) -0.92%
Return on Assets (ROA) -0.58%
Return on Capital (ROIC) -72.82%
Revenue Per Employee 0
Profits Per Employee -993.70K
Employee Count 376
Asset Turnover 0
Inventory Turnover 0

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by 45.49% in the last 52 weeks. The beta is -0.47, so Madrigal Pharmaceuticals 's price volatility has been lower than the market average.

Beta -0.47
52-Week Price Change 45.49%
50-Day Moving Average 315.26
200-Day Moving Average 261.92
Relative Strength Index (RSI) 57.16
Average Volume (20 Days) 471.97K

Income Statement

Revenue n/a
Gross Profit -527.00K
Operating Income -380.50M
Net Income -373.63M
EBITDA -379.97M
EBIT n/a
Earnings Per Share (EPS) -19.99
Full Income Statement

Balance Sheet

The company has 99.92M in cash and 117.19M in debt, giving a net cash position of -17.28M.

Cash & Cash Equivalents 99.92M
Total Debt 117.19M
Net Cash -17.28M
Retained Earnings -1.34B
Total Assets 1.07B
Working Capital 885.82M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -324.23M and capital expenditures -1.48M, giving a free cash flow of -325.71M.

Operating Cash Flow -324.23M
Capital Expenditures -1.48M
Free Cash Flow -325.71M
FCF Per Share -17.43
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MDGL does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -6.16%
FCF Yield -4.6%
Dividend Details

Analyst Forecast

The average price target for MDGL is $377, which is 16.2% higher than the current price. The consensus rating is "Buy".

Price Target $377
Price Target Difference 16.2%
Analyst Consensus Buy
Analyst Count 13
Stock Forecasts

Stock Splits

The last stock split was on Jul 25, 2016. It was a backward split with a ratio of 1:35.

Last Split Date Jul 25, 2016
Split Type backward
Split Ratio 1:35

Scores

Altman Z-Score 10.22
Piotroski F-Score 4

We use cookies to ensure that we give you the best experience on our website. Read Privacy Policy.